Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/65095
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHickey, T.-
dc.contributor.authorNorman, R.-
dc.date.issued2010-
dc.identifier.citationNature Reviews Endocrinology, 2010; 6(6):305-307-
dc.identifier.issn1759-5029-
dc.identifier.issn1759-5037-
dc.identifier.urihttp://hdl.handle.net/2440/65095-
dc.description.abstractHyperandrogenism is the key pathologic feature of polycystic ovary syndrome, but diagnostic assessment of androgen excess in women is problematic, and the biochemical assays in routine clinical practice are largely considered uninformative. is it time to add new diagnostic modalities to the clinical toolbox and perhaps measure levels of estrogen instead?-
dc.description.statementofresponsibilityTheresa E. Hickey and Robert J. Norman-
dc.language.isoen-
dc.publisherNature Publishing Group-
dc.rights© 2010 Macmillan Publishers Limited. All rights reserved-
dc.source.urihttp://dx.doi.org/10.1038/nrendo.2010.68-
dc.subjectHumans-
dc.subjectPolycystic Ovary Syndrome-
dc.subjectAndrogens-
dc.subjectEstrogens-
dc.subjectFemale-
dc.subjectBiomarkers-
dc.titleBiomarkers: Polycystic ovary syndrome: steroid assessment for diagnosis-
dc.typeJournal article-
dc.identifier.doi10.1038/nrendo.2010.68-
pubs.publication-statusPublished-
dc.identifier.orcidHickey, T. [0000-0002-2752-730X]-
dc.identifier.orcidNorman, R. [0000-0002-3118-3896]-
Appears in Collections:Aurora harvest
Obstetrics and Gynaecology publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.